Article Details

Cantor Fitzgerald Reiterates $50.00 Price Target for Aclaris Therapeutics (NASDAQ:ACRS)

Retrieved on: 2018-06-01 06:30:00

Tags for this article:

Click the tags to see associated articles and topics

Cantor Fitzgerald Reiterates $50.00 Price Target for Aclaris Therapeutics (NASDAQ:ACRS). View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc bought a new stake in Aclaris Therapeutics during the first quarter worth approximately $26,972,000. Citadel Advisors LLC ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up